NCT03512275 A Study of Bermekimab in Patients With Hidradenitis Suppurativa Status COMPLETED Phase PHASE2
NCT03289585 A National Registry For Patients With Hidradenitis Suppurativa Status COMPLETED Phase N/A
NCT03288337 Impact of Hidradenitis Suppurativa on Quality of Life Functions Status COMPLETED Phase N/A
NCT03275870 Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa Status COMPLETED Phase PHASE1/PHASE2
NCT03248531 A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa. Status COMPLETED Phase PHASE2
NCT03221621 Cost-effectiveness of Adalimumab and Surgery vs Adalimumab in HS Status UNKNOWN Phase PHASE4
NCT03198390 Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions Status TERMINATED Phase N/A
NCT03103074 Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa Status COMPLETED Phase NA
NCT03099980 Exploratory Trial Evaluating Cosentyx (Secukinumab) for Patients With Moderate-to-Severe Hidradenitis Suppurativa Status COMPLETED Phase EARLY_PHASE1
NCT03054155 Treatment of Hidradenitis Suppurativa With Eth 755nm Alexandrite Laser Status COMPLETED Phase NA
NCT03049267 Short-term Safety, Efficacy and Mode of Action of Apremilast in Moderate Suppurative Hidradenitis Status COMPLETED Phase PHASE2
NCT03001622 Studying Complement Inhibition in Patients With Moderate to Severe Hidradenitis Suppurativa Status COMPLETED Phase PHASE2
NCT02904902 Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa Status COMPLETED Phase PHASE3
NCT02833909 Activation of a Cutaneous Inflammasome in the Skin of Hidradenitis Suppurativa Patients Status COMPLETED Phase NA
NCT02805595 Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa Status COMPLETED Phase PHASE2
NCT02786576 Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting Status COMPLETED Phase N/A